文献速递心力衰竭与心肌病冠心病

Pim1激酶过表达增强猪心肌梗死后ckit+心脏干细胞的修复作用

Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.
PubMed 文献 · J Am Coll Cardiol · 2016-01-01

在免疫抑制的Yorkshire猪心肌梗死模型中,心肌内注射过表达Pim1的人ckit+心脏干细胞(Pim1+组)较未修饰的心脏干细胞(hCSC组)在注射后8周产生约3倍的瘢痕质量下降(-29.2±2.7% vs -8.4±0.7%,p<0.003)和2倍存活心肌增加(113.7±7.2% vs 65.6±6.8%,p<0.003),且仅Pim1+组射血分数改善在8周时维持。

要点

  • Pim1+组较hCSC组8周瘢痕质量下降约3倍(-29.2±2.7% vs -8.4±0.7%,p<0.003)。
  • Pim1+组较hCSC组8周存活心肌增加2倍(113.7±7.2% vs 65.6±6.8%,p<0.003)。
  • 两种细胞均改善4周射血分数,仅Pim1+组8周时较安慰剂维持改善。

核心结论

  • Pim1过表达增强了心肌内注射心脏干细胞对梗死猪心脏的修复效果,为干细胞的基因修饰及其向临床试验转化提供了依据。

研究设计与样本

  • 在免疫抑制的Yorkshire猪心肌梗死模型中,心肌梗死后2周心肌内注射人心脏干细胞(n=10)、过表达Pim1的人ckit+心脏干细胞(n=9)或安慰剂(n=10),共29只猪。
  • 细胞给药前后行心脏磁共振和压力容积环检查。

主要发现

  • 注射后8周,Pim1+组瘢痕质量降幅约3倍于hCSC组(-29.2±2.7% vs -8.4±0.7%,p<0.003)。
  • 注射后8周,Pim1+组存活心肌增幅2倍于hCSC组(113.7±7.2% vs 65.6±6.8%,p<0.003)。
  • Pim1+组在梗死区和边缘区局部收缩力增幅均大于hCSC组(均p<0.05)。
  • 两种细胞类型均在4周时显著提高射血分数,但8周时仅Pim1+组较安慰剂维持该改善。
  • hCSC组和Pim1+组均降低后负荷(分别为p=0.02和p=0.004),Pim1+组机械能量耦合改善更显著(p=0.005)。

临床怎么用

  • 原文结论认为Pim1过表达增强了心脏干细胞心肌内递送对梗死猪心脏的修复效果,为干细胞的基因修饰及后续向临床试验转化提供了依据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pim1 kinase plays an important role in cell division, survival, and commitment of precursor cells towards a myocardial lineage, and overexpression of Pim1 in ckit+ cardiac stem cells (CSCs) enhances their cardioreparative properties. OBJECTIVES: The authors sought to validate the effect of Pim1-modified CSCs in a translationally relevant large animal preclinical model of myocardial infarction (MI). METHODS: Human cardiac stem cells (hCSCs, n = 10), hckit+ CSCs overexpressing Pim1 (Pim1+; n = 9), or placebo (n = 10) were delivered by intramyocardial injection to immunosuppressed Yorkshire swine (n = 29) 2 weeks after MI. Cardiac magnetic resonance and pressure volume loops were obtained before and after cell administration. RESULTS: Whereas both hCSCs reduced MI size compared to placebo, Pim1+ cells produced a ∼3-fold greater decrease in scar mass at 8 weeks post-injection compared to hCSCs (-29.2 ± 2.7% vs. -8.4 ± 0.7%; p < 0.003). Pim1+ hCSCs also produced a 2-fold increase of viable mass compared to hCSCs at 8 weeks (113.7 ± 7.2% vs. 65.6 ± 6.8%; p <0.003), and a greater increase in regional contractility in both infarct and border zones (both p < 0.05). Both CSC types significantly increased ejection fraction at 4 weeks but this was only sustained in the Pim1+ group at 8 weeks compared to placebo. Both hCSC and Pim1+ hCSC treatment reduced afterload (p = 0.02 and p = 0.004, respectively). Mechanoenergetic recoupling was significantly greater in the Pim1+ hCSC group (p = 0.005). CONCLUSIONS: Pim1 overexpression enhanced the effect of intramyocardial delivery of CSCs to infarcted porcine hearts. These findings provide a rationale for genetic modification of stem cells and consequent translation to clinical trials.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kulandavelu S, Karantalis V, Fritsch J, et al. Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine. J Am Coll Cardiol. 2016. PMID: 27908351. doi:10.1016/j.jacc.2016.09.925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。